• Eylea provides a therapeutic option for patients with sight-threatening retinal disorders. The drug’s ability to neutralize VEGF prevents damage to retinal blood vessels, preserving vision. With years of clinical use and data backing its benefits, Eylea continues to be a trusted solution in ophthalmology. https://www.marketresearchfuture.com/reports/eylea-market-21316